reports
- Hiroyuki Terada
- Hiroyuki Terada
PSA Small-Caps: CUC (9158 JT) FY24 Q2 Results Comment
Specialized hospice provider CUC (9158 JT) announced better than expected FY24 Q2 results and yet has not revised up for the full year. Analyst Hiroyuki Terada explains the reasons why and notes he will review the outlook after his scheduled meeting with management on 5 Nov..
- Hiroyuki Terada
PSA Healthcare Services: CUC (9158 JT) Update – Post Earnings Drop Val...
Small-cap specialist Hiroyuku Terada updates his forecasts for hospice facility operator CUC. He concludes that valuations remain attractive and notes that the -30% decline in the shares since the release of its new FY24 guidance on 24 April creates an opportunity to consider taking a position.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.